The cannabis industry, and more specifically the cannabidiol (CBD) market, is predicted to become a billion-dollar business within the next few years. Since CBD-only products provide many of the medicinal benefits of cannabis without any of the psychoactive effects, the CBD market has potential to grow in ways that other segments in the medicinal and recreational cannabis market don’t.

As the medical industry and society begin to understand that cannabinoids can do a lot more than just get people high, CBD products have become a natural fit in the health and wellness market, as well as the pet care and even skin care industries.

Companies that are looking to break into this market need to be very innovative with their offerings if they want to stand out from the crowd. Just as with any other consumer product market, diversification of products can enhance competitiveness, brand recognition, and profitability. Product diversification is essential for brands who want to avoid fading into the background of the CBD market. CW Hemp is currently one of the best out there.

GW Pharmaceuticals are one of the front-runners in the CBD market since they introduced Epidiolex - the first FDA approved drug made from cannabis. Epidiolex was specifically approved to treat Lennox-Gastaut syndrome and Dravet syndrome, two rare and severe forms of epilepsy that often begin in childhood.

This is possibly among the most significant moves in the CBD industry since CBD produced such positive results. In reality, Epidiolex, which contains CBD as its main active ingredient, is able to do what traditional medical products cannot. Therefore, any medical products that were used previously to treat these conditions and maybe even epilepsy, in general, could potentially become obsolete. Why use another product when Epidiolex has proven to be a lot more efficient and effective?

A recent study conducted by The Brightfield Group found that more and more people were opting for CBD over other pharmaceuticals. 69% of the survey respondents stated that CBD products were either “more effective” or “much more effective” in treating various conditions and illnesses than over-the-counter pharmaceuticals. In other words, CBD companies are taking business from traditional medical companies since many people are finding more relief from CBD.

The truth is that people are getting frustrated with traditional medicine and are searching for more natural health solutions, even considering methods that they might never have considered before. People from all walks of life are beginning to use CBD and adding it to their wellness routine. Although it might have seemed taboo a few years ago because it’s derived from cannabis, people are beginning to understand that it’s completely safe and effective. This causes quite the dilemma for the traditional medical products industry.

But, the fact is that there is a medical revolution that is taking place. This is just the beginning for CBD companies. Over the next few years, we are expected to see an increasing number of people who turn to CBD for relief. Before we know it, CBD companies will be at the frontier of the medical industry.